Put companies on watchlist
MPH Health Care AG
ISIN: DE000A289V03
WKN: A289V0
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

MPH Health Care AG · ISIN: DE000A289V03 · EQS - Company News (41 News)
Country: Germany · Primary market: Germany · EQS NID: 1830413
05 February 2024 01:00PM

MPH Health Care AG sells 1.5 million shares in its investment M1 Kliniken AG to its Management Board members


EQS-News: MPH Health Care AG / Key word(s): Investment
MPH Health Care AG sells 1.5 million shares in its investment M1 Kliniken AG to its Management Board members

05.02.2024 / 13:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


On February 2, 2024, MPH Health Care AG successfully sold 1.5 million shares in its investment M1 Kliniken AG to the two members of the management board of M1 Kliniken AG, Mr. Attila Strauss and Mr. Kilian Brenske. The two Co-CEOs acquired the share package in order to strengthen their entrepreneurial commitment. The transaction underlines the management's confidence in the long-term performance of M1 Kliniken AG.
 
MPH Health Care AG CEO, Patrick Brenske, says: "I welcome the management's move to acquire a stake in M1 Kliniken AG. In the past 15 months, the two Co-CEOs have almost doubled the value of the company. It strengthens the motivation to continue to manage the company sustainably and to create long-term value for all shareholders. The scaling of the business model is promoted by this share purchase, as the Co-CEOs now have an even stronger incentive to drive the growth of M1 Kliniken."

About MPH Health Care AG:
MPH AG is an investment company with a strategic focus on the acquisition, development and sale of companies and company shares, particularly in growth segments of the healthcare market. This includes both insurance-financed and privately financed segments. But MPH also exploits potential from high-growth and high-return sectors outside the healthcare market.
Contact:
Corporate Communications
E-Mail: ir@mph-ag.de


05.02.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: MPH Health Care AG
Grünauer Straße 5
12557 Berlin
Germany
Phone: 030 / 863 21 45 60
Fax: 030 / 863 21 45 69
E-mail: info@mph-ag.de
Internet: www.mph-ag.de
ISIN: DE000A289V03, DE000A289VT5
WKN: A289V0
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1830413

 
End of News EQS News Service

1830413  05.02.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1830413&application_name=news&site_id=boersengefluester_html
Visual performance / price development - MPH Health Care AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.